Clinical Trial Update: Pharmacokinetic Evaluation of an Intensified and Decreasing Dosing Regimen of Mycophenolate Sodium in Combination With Tacrolimus Post Kidney Transplant: The Myfortic Study [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study evaluating an intensified and decreasing dosing regimen of mycophenolate sodium in combination with tacrolimus after kidney transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Mycophenolate sodium (Myfortic) (mycophenolate sodium)
• Tacrolimus (Prograf) (tacrolimus)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED